In his latest research note, analyst Douglas S. Harned confirms his positive recommendation. The broker Bernstein is keeping its Buy rating. The target price is unchanged and still at USD 239.
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.